Journal article

Influence of Single Nucleotide Polymorphisms in COMT, MAO-A and BDNF Genes on Dyskinesias and Levodopa Use in Parkinson's Disease

Perdita Cheshire, Kelly Bertram, Helen Ling, Sean S O'Sullivan, Glenda Halliday, Catriona McLean, Jose Bras, Tom Foltynie, Elsdon Storey, David R Williams

Neurodegenerative Diseases | KARGER | Published : 2014


Awarded by Wellcome Trust

Awarded by Parkinson's UK

Awarded by Wellcome Trust/MRC

Awarded by Medical Research Council

Awarded by Parkinson"s UK


Funding Acknowledgements

We would like to thank Catherine Smith, Monash University, for her assistance with statistical modelling and Linda Parsons, QSBB, for her assistance with tissue acquisition. We thank brain donors and their families, without whom this work would not have been possible. This work was funded by the Bethlehem Griffiths Research Foundation, the Brain Foundation, the Wellcome Trust (WTCCC2, grants 084747 and 083948) and Parkinson's UK (K-0901). This work was partly undertaken at UCLH/UCL who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. Support was also received from the Wellcome Trust/MRC Joint Call in Neurodegeneration Award (WT089698) to UCL, the MRC Unit in Dundee and the University of Sheffield. The ABBN is supported by Neuroscience Research Australia, the University of New South Wales and the National Health and Medical Research Council of Australia.